Your email has been successfully added to our mailing list.

×
0 0.105527638190955 0.100502512562814 0.00502512562814071 -0.0201005025125628 0 0 -0.0603015075376884
Stock impact report

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study

Curis, Inc. (CRIS) 
Last curis, inc. earnings: 11/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.curis.com
Company Research Source: PR Newswire
Impact Snapshot
Event Time:
CRIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CRIS alerts
Opt-in for
CRIS alerts

from News Quantified
Opt-in for
CRIS alerts

from News Quantified